Zobrazeno 1 - 10
of 21
pro vyhledávání: '"H Fiegl"'
Autor:
H Fiegl, Manjiri M Bakre, S.P. Somashekhar, Christine Brunner, Aparna Gunda, Cristina Saura, Aditya K. Sengupta, Chandra Prakash V Serkad, Susanne Sprung, Patricia Gomez, Daniel Egle, José Antonio Jiménez, Vicente Peg
Publikováno v:
Cancer Research. 81:PS4-47
Background: CanAssist Breast (CAB) is a prognostic test for early stage hormone receptor positive breast cancer patients, that predicts risk of distant recurrence in five years post-diagnosis. Its support vector machine-based algorithm utilizes immun
Autor:
K Leitner, H Welponer, H Fiegl, Hubert Hackl, I Tsibulak, Verena Wieser, Alain G. Zeimet, Christian Marth
Publikováno v:
Acta Oncologica. 60:187-190
Epithelial ovarian cancer (OC) is one of the leading causes of cancer death in women in the western world [1–3]. Approximately 10–15% of all epithelial OC are hereditary and the vast majority of th...
Autor:
S Wenzel, H Welponer, Verena Wieser, Susanne Sprung, Hubert Hackl, H Fiegl, I Tsibulak, Alain G. Zeimet, Christian Marth, Giridhar Shivalingaiah, C Degasper
Publikováno v:
Journal of Cancer
The tumor suppressor miR-34 family is transcriptionally induced by p53. Clinical significance of the various miR-34 family members has not been studied in ovarian cancer. In 228 ovarian cancers and in 19 non-neoplastic fallopian tube samples we analy
Autor:
H Fiegl, Judith Hagenbuchner, AG Zeimet, I Tsibulak, Michael J. Ausserlechner, J Kögl, C Marth
Publikováno v:
Ovarian cancer.
Autor:
Alain G. Zeimet, J Kögl, Susanne Sprung, Verena Wieser, H Fiegl, Samira Abdel Azim, K Knoll, Christian Marth, Hubert Hackl
Publikováno v:
Carcinogenesis. 41(8)
Endometrial cancer (EC) is the most common gynaecologic tumour in the Western world. Previous studies have implicated an imbalance of oestrogens and progestogens in the development of most ECs, while the role of low-grade tissue inflammation remains
Autor:
Sigurd Lax, Christian Marth, S Wenzel, C Degasper, I Tsibulak, Alain G. Zeimet, H Fiegl, Susanne Sprung, Verena Wieser, Giridhar Shivalingaiah
Publikováno v:
British Journal of Cancer
Background Mutations in BRCA1 and BRCA2 are associated with better survival in ovarian cancer (OC) patients due to a better response to platinum-based chemotherapy. However, the impact of the BRCA1/2 mRNA-expression is not well characterized in OC. P
Autor:
H Welponer, C Marth, K Leitner, Hubert Hackl, H Fiegl, Verena Wieser, AG Zeimet, I Tsibulak, C Degasper, K Knoll
Publikováno v:
ePoster.
Introduction/Background Mutations in cancer susceptibility genes BRCA1/2 are considered to be associated with better survival in ovarian cancer (OC) patients possibly due to a better response to platinum based chemotherapy and PARP inhibitors. Howeve
Autor:
K Leitner, H Welponer, Annemarie Wiedemair, Verena Wieser, H Fiegl, Daniel Reimer, I Tsibulak, K Knoll, C Marth, AG Zeimet, C Degasper
Publikováno v:
Poster exhibition Day 2.
Introduction/Background The SWI/SNF complex - a chromatin remodelling complex - is recurrently mutated and inactivated in ∼20% of human cancers. Mutations of the SMARCA4 gene, which encodes the ATPase of the SWI/SNF complex, can be found in the maj
Autor:
H Welponer, S Wenzel, AG Zeimet, Verena Wieser, C Degasper, I Tsibulak, C Marth, Susanne Sprung, Giridhar Shivalingaiah, H Fiegl
Publikováno v:
Poster exhibition Day 2.
Introduction/Background The tumor suppressor miR-34 family is transcriptionally induced by p53. Clinical significance of the various miR-34 family members has not been studied in ovarian cancer. Methodology In 228 ovarian cancers and in 19 non-neopla
Autor:
Alain G. Zeimet, M Fleischer, Soeren Wenzel, Verena Wieser, H Fiegl, I Gaugg, Susanne Sprung, Christian Marth, Giridhar Shivalingaiah, Sigurd Lax
Publikováno v:
Oncotarget
// Verena Wieser 1 , Inge Gaugg 1 , Martina Fleischer 1 , Giridhar Shivalingaiah 2, 5 , Soeren Wenzel 2 , Susanne Sprung 3 , Sigurd F. Lax 4 , Alain G. Zeimet 1 , Heidelinde Fiegl 1 and Christian Marth 1 1 Department of Obstetrics and Gynecology, Med